Vanessa F. Schmidt

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis.

Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis.

Journal: Scientific reports

Published: May 18, 2026

Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neck.

Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neck.

Journal: Frontiers in neurology

Published: March 09, 2026

MR-guided microwave ablation of liver tumors: outcomes in local tumor control and determinants of treatment success.

MR-guided microwave ablation of liver tumors: outcomes in local tumor control and determinants of treatment success.

Journal: European radiology

Published: February 14, 2026

Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver.

Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver.

Journal: Cardiovascular and interventional radiology

Published: November 30, 2025

Quantitative ex vivo assessment of target temperature and ablation duration for protocol optimization of microwave ablation procedures with mr thermometry.

Quantitative ex vivo assessment of target temperature and ablation duration for protocol optimization of microwave ablation procedures with mr thermometry.

Journal: Scientific reports

Published: November 24, 2025

Prospective analysis of bleomycin electrosclerotherapy for clinical outcome and volume reduction in therapy refractory slow-flow malformations.

Prospective analysis of bleomycin electrosclerotherapy for clinical outcome and volume reduction in therapy refractory slow-flow malformations.

Journal: CVIR endovascular

Published: August 26, 2025

Pre- and Periprocedural Imaging Predicts Technical but not Clinical Success of Prostatic Artery Embolization Using Non-spherical PVA Particles-Insights From the Prospective PROEMBO Trial.

Pre- and Periprocedural Imaging Predicts Technical but not Clinical Success of Prostatic Artery Embolization Using Non-spherical PVA Particles-Insights From the Prospective PROEMBO Trial.

Journal: Academic radiology

Published: August 07, 2025

Detection of spike protein in term placentas of COVID-19 vaccinated and/or SARS-CoV-2 infected women.

Detection of spike protein in term placentas of COVID-19 vaccinated and/or SARS-CoV-2 infected women.

Journal: PloS one

Published: July 13, 2025

XYLT1 Deficiency of Human Mesenchymal Stem Cells: Impact on Osteogenic, Chondrogenic, and Adipogenic Differentiation.

XYLT1 Deficiency of Human Mesenchymal Stem Cells: Impact on Osteogenic, Chondrogenic, and Adipogenic Differentiation.

Journal: International journal of molecular sciences

Published: June 20, 2025

Bleomycin Electrosclerotherapy (BEST) for treatment of slow-flow vascular malformations in children.

Bleomycin Electrosclerotherapy (BEST) for treatment of slow-flow vascular malformations in children.

Journal: Pediatric research

Published: June 12, 2025

Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous Malformations.

Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous Malformations.

Journal: Cardiovascular and interventional radiology

Published: June 02, 2025

Safety and Clinical Outcome of Bleomycin-Electrosclerotherapy (BEST) Treating Lymphatic Malformations (LMs).

Safety and Clinical Outcome of Bleomycin-Electrosclerotherapy (BEST) Treating Lymphatic Malformations (LMs).

Journal: Cardiovascular and interventional radiology

Published: May 11, 2025

Showing 1-12 of 59

Last Updated: 09/26/2026